COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials | Read

PUBLISHED ON: June 30, 2020 | Duration: 0 min, 58 sec

facebooktwitteremailkoo
loading..
A potential COVID-19 vaccine, the first to be developed in India, has been given DCGI (Drug Controller General of India) approval for Phase I and II human clinical trials that are scheduled to start across the country in July. Developed by Hyderabad-based Bharat Biotech, in association with ICMR (Indian Council for Medical Research), COVAXIN is an inactivated vaccine, created from a strain of the infectious SARS-CoV-2 virus, that has shown promise in preclinical studies, demonstrating extensive safety and effective immune responses.
ALSO WATCH
Corbevax Cleared As Covid Booster Shot For 18 And Above

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com